Antibiotics for exacerbations of chronic obstructive pulmonary disease
46 results
1 - 46
Antibiotics for exacerbations of chronic obstructive pulmonary disease- Antibiotics for exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review
- Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease
- Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease
- Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
- Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease
- Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease
- Methylxanthines for exacerbations of chronic obstructive pulmonary disease
- Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)
- Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
- Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease
- Vitamin D for the management of chronic obstructive pulmonary disease
- Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta‐analysis
- Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD)
- Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease: Cochrane systematic review
- Aclidinium bromide for stable chronic obstructive pulmonary disease
- Long-acting beta 2 -agonists for chronic obstructive pulmonary disease: Cochrane systematic review
- Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review
- Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD)
- Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease
- Anti‐IL‐5 therapies for chronic obstructive pulmonary disease
- Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease
- Integrated disease management interventions for patients with chronic obstructive pulmonary disease
- Self‐management for bronchiectasis
- Zinc for the common cold: Cochrane systematic review
- Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections